Genomictree Inc. (KOSDAQ:228760)
20,750
+700 (3.49%)
At close: Feb 27, 2026
Genomictree Market Cap
Genomictree has a market cap or net worth of 503.53 billion as of February 27, 2026. Its market cap has increased by 19.26% in one year.
Market Cap
503.53B
Enterprise Value
420.70B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,750.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 503.53B, an increase of 753.46%. That is a compound annual growth rate of 27.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 503.53B | -23.64% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 906.25B |
| Proteina | 867.50B |
| MEDIPOST | 840.34B |
| Green Cross Holdings | 724.16B |
| SillaJen | 509.70B |
| BINEX | 475.49B |
| GC Cell | 368.16B |
| JETEMA, | 367.28B |